OBJECTIVE: To report the design and implementation of the first 3 years of enrollment of the Mayo Clinic Biobank. PATIENTS AND METHODS: Preparations for this biobank began with a 4-day Deliberative Community Engagement with local residents to obtain community input into the design and governance of the biobank. Recruitment, which began in April 2009, is ongoing, with a target goal of 50,000. Any Mayo Clinic patient who is 18 years or older, able to consent, and a US resident is eligible to participate. Each participant completes a health history questionnaire, provides a blood sample, and allows access to existing tissue specimens and all data from their Mayo Clinic electronic medical record. A community advisory board provides ongoing advice and guidance on complex decisions. RESULTS: After 3 years of recruitment, 21,736 individuals have enrolled. Fifty-eight percent (12,498) of participants are female and 95% (20,541) of European ancestry. Median participant age is 62 years. Seventy-four percent (16,171) live in Minnesota, with 42% (9157) from Olmsted County, where the Mayo Clinic in Rochester, Minnesota, is located. The 5 most commonly self-reported conditions are hyperlipidemia (8979, 41%), hypertension (8174, 38%), osteoarthritis (6448, 30%), any cancer (6224, 29%), and gastroesophageal reflux disease (5669, 26%). Among patients with self-reported cancer, the 5 most common types are nonmelanoma skin cancer (2950, 14%), prostate cancer (1107, 12% in men), breast cancer (941, 4%), melanoma (692, 3%), and cervical cancer (240, 2% in women). Fifty-six percent (12,115) of participants have at least 15 years of electronic medical record history. To date, more than 60 projects and more than 69,000 samples have been approved for use. CONCLUSION: The Mayo Clinic Biobank has quickly been established as a valuable resource for researchers.
OBJECTIVE: To report the design and implementation of the first 3 years of enrollment of the Mayo Clinic Biobank. PATIENTS AND METHODS: Preparations for this biobank began with a 4-day Deliberative Community Engagement with local residents to obtain community input into the design and governance of the biobank. Recruitment, which began in April 2009, is ongoing, with a target goal of 50,000. Any Mayo Clinic patient who is 18 years or older, able to consent, and a US resident is eligible to participate. Each participant completes a health history questionnaire, provides a blood sample, and allows access to existing tissue specimens and all data from their Mayo Clinic electronic medical record. A community advisory board provides ongoing advice and guidance on complex decisions. RESULTS: After 3 years of recruitment, 21,736 individuals have enrolled. Fifty-eight percent (12,498) of participants are female and 95% (20,541) of European ancestry. Median participant age is 62 years. Seventy-four percent (16,171) live in Minnesota, with 42% (9157) from Olmsted County, where the Mayo Clinic in Rochester, Minnesota, is located. The 5 most commonly self-reported conditions are hyperlipidemia (8979, 41%), hypertension (8174, 38%), osteoarthritis (6448, 30%), any cancer (6224, 29%), and gastroesophageal reflux disease (5669, 26%). Among patients with self-reported cancer, the 5 most common types are nonmelanoma skin cancer (2950, 14%), prostate cancer (1107, 12% in men), breast cancer (941, 4%), melanoma (692, 3%), and cervical cancer (240, 2% in women). Fifty-six percent (12,115) of participants have at least 15 years of electronic medical record history. To date, more than 60 projects and more than 69,000 samples have been approved for use. CONCLUSION: The Mayo Clinic Biobank has quickly been established as a valuable resource for researchers.
Keywords:
BMI; BRFSS; Behavioral Risk Factor Surveillance System Survey; CAB; Community Advisory Board; DCE; Deliberative Community Engagement; EMR; WBC; body mass index; electronic medical record; white blood cell
Authors: Wenjun Zhong; Hilal Maradit-Kremers; Jennifer L St Sauver; Barbara P Yawn; Jon O Ebbert; Véronique L Roger; Debra J Jacobson; Michaela E McGree; Scott M Brue; Walter A Rocca Journal: Mayo Clin Proc Date: 2013-06-19 Impact factor: 7.616
Authors: J L Ridgeway; L C Han; J E Olson; K A Lackore; B A Koenig; T J Beebe; J Y Ziegenfuss Journal: Public Health Genomics Date: 2013-04-12 Impact factor: 2.000
Authors: Marissa J Schafer; Xu Zhang; Amanika Kumar; Elizabeth J Atkinson; Yi Zhu; Sarah Jachim; Daniel L Mazula; Ashley K Brown; Michelle Berning; Zaira Aversa; Brian Kotajarvi; Charles J Bruce; Kevin L Greason; Rakesh M Suri; Russell P Tracy; Steven R Cummings; Thomas A White; Nathan K LeBrasseur Journal: JCI Insight Date: 2020-06-18
Authors: Cody C Wyles; Christopher R Paradise; Matthew T Houdek; Susan L Slager; Andre Terzic; Atta Behfar; Andre J van Wijnen; Rafael J Sierra Journal: Clin Orthop Relat Res Date: 2019-08 Impact factor: 4.176
Authors: Iftikhar J Kullo; Hayan Jouni; Erin E Austin; Sherry-Ann Brown; Teresa M Kruisselbrink; Iyad N Isseh; Raad A Haddad; Tariq S Marroush; Khader Shameer; Janet E Olson; Ulrich Broeckel; Robert C Green; Daniel J Schaid; Victor M Montori; Kent R Bailey Journal: Circulation Date: 2016-02-25 Impact factor: 29.690
Authors: Peter S Jensen; Mark A Frye; Joanna M Biernacka; Paul E Croarkin; Joan L Luby; Kelly Cercy; Jennifer R Geske; Marin Veldic; Matthew Simonson; Paramjit T Joshi; Karen Dineen Wagner; John T Walkup; Malik M Nassan; Alfredo B Cuellar-Barboza; Leah Casuto; Susan L McElroy Journal: J Clin Psychiatry Date: 2017 Nov/Dec Impact factor: 4.384
Authors: Vanessa L Kronzer; Cynthia S Crowson; Jeffrey A Sparks; Robert Vassallo; John M Davis Journal: Arthritis Rheumatol Date: 2019-07-01 Impact factor: 10.995
Authors: Suzette J Bielinski; Jennifer L St Sauver; Janet E Olson; Nicholas B Larson; John L Black; Steven E Scherer; Matthew E Bernard; Eric Boerwinkle; Bijan J Borah; Pedro J Caraballo; Timothy B Curry; HarshaVardhan Doddapaneni; Christine M Formea; Robert R Freimuth; Richard A Gibbs; Jyothsna Giri; Matthew A Hathcock; Jianhong Hu; Debra J Jacobson; Leila A Jones; Sara Kalla; Tyler H Koep; Viktoriya Korchina; Christie L Kovar; Sandra Lee; Hongfang Liu; Eric T Matey; Michaela E McGree; Tammy M McAllister; Ann M Moyer; Donna M Muzny; Wayne T Nicholson; Lance J Oyen; Xiang Qin; Ritika Raj; Véronique L Roger; Carolyn R Rohrer Vitek; Jason L Ross; Richard R Sharp; Paul Y Takahashi; Eric Venner; Kimberly Walker; Liwei Wang; Qiaoyan Wang; Jessica A Wright; Tsung-Jung Wu; Liewei Wang; Richard M Weinshilboum Journal: Int J Epidemiol Date: 2020-02-01 Impact factor: 7.196
Authors: Robert R McWilliams; Eric D Wieben; Kari G Chaffee; Samuel O Antwi; Leon Raskin; Olufunmilayo I Olopade; Donghui Li; W Edward Highsmith; Gerardo Colon-Otero; Lauren G Khanna; Jennifer B Permuth; Janet E Olson; Harold Frucht; Jeanine Genkinger; Wei Zheng; William J Blot; Lang Wu; Luciana L Almada; Martin E Fernandez-Zapico; Hugues Sicotte; Katrina S Pedersen; Gloria M Petersen Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-07-23 Impact factor: 4.254
Authors: Rentian Wu; Qian Nie; Erin E Tapper; Calvin R Jerde; Garrett S Dunlap; Shikshya Shrestha; Tarig A Elraiyah; Steven M Offer; Robert B Diasio Journal: Cancer Res Date: 2016-08-30 Impact factor: 12.701